← Open Payments lookup

MATTHEW SARCONA: Open Payments

NPI 1427603604 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$333 in 14 payments from 8 companies in 2025. Trend: 2023 $177 · 2024 $241 · 2025 $333

Food & beverage: $333
CompanyPaymentsAmount
Alnylam Pharmaceuticals Inc.3$77
BridgeBio Pharma, Inc.4$77
Kestra Medical Technology Services, Inc.1$46
Novo Nordisk Inc2$40
Boehringer Ingelheim Pharmaceuticals, Inc.1$26
E.R. Squibb & Sons, L.L.C.1$23
AstraZeneca Pharmaceuticals LP1$22
Actelion Pharmaceuticals US, Inc.1$22

Products named: AMVUTTRA, Attruby, Assure WCD, Wegovy, JARDIANCE, CAMZYOS, WAINUA, UPTRAVI.

Industry payments across NY — which companies pay providers there.